As illustrated in Figs. 6A–6E, expression levels of TRIP13, TPX2, DLGAP5, KIF2C and TTK were associated with shorter disease free survival (DFS) among differentiated thyroid cancer. Here, KIF2C is linked to thyroid gland carcinoma.